<rst>
<header>
	<relations>
			<rel name="purpose" type="rst"/>
			<rel name="result" type="rst"/>
			<rel name="background" type="rst"/>
			<rel name="circumstance" type="rst"/>
			<rel name="elaboration" type="rst"/>
			<rel name="concession" type="rst"/>
			<rel name="antithesis" type="rst"/>
			<rel name="restatement" type="rst"/>
			<rel name="attribution" type="rst"/>
			<rel name="joint" type="multinuc"/>
			<rel name="sequence" type="multinuc"/>
			<rel name="same_unit" type="multinuc"/>
		</relations>
</header>
<body>
<segment id="1" parent="1001" relname="span">Geriatric syndrome refers to a series of symptoms and observations</segment>
<segment id="2" parent="1002" relname="span">caused by a variety of factors</segment>
<segment id="3" parent="1003" relname="span">associated with aging ,</segment>
<segment id="4" parent="1004" relname="joint">where the older adults show the treatment consciously or otherwise ,</segment>
<segment id="5" parent="1004" relname="joint">and long-term care becomes important at the same time .</segment>
<segment id="6" parent="1008" relname="span">With respect to geriatric syndrome , often the viewpoint involves the purpose</segment>
<segment id="7" parent="1009" relname="span">of sustaining the capability for activities of daily living</segment>
<segment id="8" parent="7" relname="restatement">( ADL )</segment>
<segment id="9" parent="1011" relname="span">and improving the quality of life</segment>
<segment id="10" parent="9" relname="elaboration">( QOL ) ,</segment>
<segment id="11" parent="1011" relname="antithesis">rather than just considering the disease condition according to the diagnostic name .</segment>
<segment id="12" parent="1013" relname="span">Notably , there are geriatric syndrome symptoms</segment>
<segment id="13" parent="12" relname="elaboration">that are more frequent</segment>
<segment id="14" parent="1015" relname="span">and are largely affected by long-term care , such as , disorders</segment>
<segment id="15" parent="1016" relname="span">associated with mobility</segment>
<segment id="16" parent="15" relname="elaboration">( remain secluded , or bedridden ) ,</segment>
<segment id="17" parent="1014" relname="same_unit">falls , incontinence , and cognitive impairment .</segment>
<segment id="18" parent="1019" relname="span">These are considered issues</segment>
<segment id="19" parent="18" relname="elaboration">for which early measures should be incorporated into geriatric treatment .</segment>
<segment id="20" parent="1021" relname="span">In recent years , measures against frailty and sarcopenia ,</segment>
<segment id="21" parent="1022" relname="span">which elevate the risk</segment>
<segment id="22" parent="21" relname="elaboration">of increasing the need for long-term care ,</segment>
<segment id="23" parent="1020" relname="same_unit">are being considered important .</segment>
<segment id="24" parent="1024" relname="span">Frailty progresses</segment>
<segment id="25" parent="1026" relname="span">as vulnerability to stress increases</segment>
<segment id="26" parent="25" relname="restatement">due to declining physiological reserves with aging ,</segment>
<segment id="27" parent="1026" relname="result">making one prone to unhealthy conditions .</segment>
<segment id="28" parent="1028" relname="span">It is a factor</segment>
<segment id="29" parent="28" relname="elaboration">that increases the risk of falling , disabilities in activities of daily living , onset of the need for long-term care , and death .</segment>
<segment id="30" parent="1031" relname="joint">Frailty as a concept includes not only physical problems , such as the representative decline in muscle strength ,</segment>
<segment id="31" parent="1031" relname="joint">but also mental and physical problems , such as cognitive impairment and depression .</segment>
<segment id="32" parent="1032" relname="span">It also includes social problems , such as solitary living and economic distress .</segment>
<segment id="33" parent="32" relname="elaboration">Accordingly , it needs to be considered comprehensively .</segment>
<segment id="34" parent="1033" relname="joint">Frailty is said to be reversible .</segment>
<segment id="35" parent="1036" relname="attribution">Therefore , it is expected</segment>
<segment id="36" parent="1036" relname="sequence">that appropriate intervention for frail older adults will lead to improvements in physical function and daily living capabilities ,</segment>
<segment id="37" parent="1037" relname="sequence">help reverse frailty ,</segment>
<segment id="38" parent="1037" relname="sequence">and prevent the onset of functional disorders .</segment>
<segment id="39" parent="1038" relname="joint">For prevention and improvement of frailty , the key points will be active promotion of early identification of risk and desirable interventions as early measures .</segment>
<segment id="40" parent="1041" relname="span">“ Sarcopenia ” is a coined word ,</segment>
<segment id="41" parent="1042" relname="span">where “ sarx</segment>
<segment id="42" parent="41" relname="restatement">( sarco ) ”</segment>
<segment id="43" parent="1043" relname="joint">means muscle</segment>
<segment id="44" parent="1044" relname="joint">and “ penia ” means “ loss and reduction ” in Greek ,</segment>
<segment id="45" parent="1044" relname="joint">and it was first proposed by Rosenberg in 1989 .</segment>
<segment id="46" parent="1046" relname="span">Originally , it had a strong physiological nuance of decrease</segment>
<segment id="47" parent="46" relname="elaboration">( atrophy ) in muscle mass with aging .</segment>
<segment id="48" parent="1049" relname="span">However , in addition to primary</segment>
<segment id="49" parent="1050" relname="span">( aging ) sarcopenia , a broader definition is taking hold ,</segment>
<segment id="50" parent="49" relname="elaboration">which includes as secondary sarcopenia the reduction in muscle mass and muscle strength and further muscle function loss ,</segment>
<segment id="51" parent="1051" relname="span">due to factors</segment>
<segment id="52" parent="51" relname="elaboration">associated with activity , disease , and nutrition .</segment>
<segment id="53" parent="1053" relname="span">In 2016 , sarcopenia was registered in the International Classification of Diseases</segment>
<segment id="54" parent="53" relname="restatement">( ICD-10 ) .</segment>
<segment id="55" parent="1055" relname="joint">It is now considered as a disease ,</segment>
<segment id="56" parent="1055" relname="joint">and measures for the prevention , treatment , and improvement of sarcopenia are urgently needed in the future .</segment>
<segment id="57" parent="1059" relname="attribution">It has been reported</segment>
<segment id="58" parent="1059" relname="same_unit">that in frail older adults , exercise intervention is effective</segment>
<segment id="59" parent="1059" relname="same_unit">in improving physical functions , including gait speed .</segment>
<segment id="60" parent="1060" relname="joint">However , the effects of the recommended specific event , frequency , and time have not been clarified .</segment>
<segment id="61" parent="1062" relname="span">In addition to strength training , multifaceted exercise programs</segment>
<segment id="62" parent="61" relname="elaboration">that incorporate flexible exercise , balance exercise , and aerobic exercise have also been reported to improve muscle strength in frail older adults .</segment>
<segment id="63" parent="1064" relname="attribution">It has been suggested</segment>
<segment id="64" parent="1067" relname="span">that interventions</segment>
<segment id="65" parent="64" relname="elaboration">focused on the physical elements behind frailty</segment>
<segment id="66" parent="1067" relname="elaboration">( weight loss , muscle weakness , exhaustion , slowness , low physical activity )</segment>
<segment id="67" parent="1065" relname="same_unit">are effective ,</segment>
<segment id="68" parent="1068" relname="span">and comprehensive interventions</segment>
<segment id="69" parent="1069" relname="same_unit">incorporating as many of the elements</segment>
<segment id="70" parent="1069" relname="same_unit">as possible are desirable .</segment>
<segment id="71" parent="1072" relname="span">Resistance training and nutritional</segment>
<segment id="72" parent="71" relname="restatement">( protein )</segment>
<segment id="73" parent="1071" relname="same_unit">interventions are often selected as measures for prevention and improvement of sarcopenia .</segment>
<segment id="74" parent="1075" relname="span">In a report on increased muscle mass and muscle strength in older adults , a high load of 70 – 80 % of 1 repetition maximum</segment>
<segment id="75" parent="74" relname="restatement">( RM )</segment>
<segment id="76" parent="1074" relname="same_unit">was used .</segment>
<segment id="77" parent="1078" relname="attribution">However , for older adults without exercise habits , it was reported</segment>
<segment id="78" parent="1078" relname="span">that even with a load of 40 – 50 % of 1 RM</segment>
<segment id="79" parent="78" relname="elaboration">improvement in muscle function can be expected .</segment>
<segment id="80" parent="81" relname="circumstance">When setting a low load cannot be avoided ,</segment>
<segment id="81" parent="1080" relname="span">long-term and high frequency interventions may be necessary .</segment>
<segment id="82" parent="1085" relname="span">Moreover , nutritional interventions for the purpose</segment>
<segment id="83" parent="82" relname="elaboration">of promoting muscle protein synthesis</segment>
<segment id="84" parent="1085" relname="elaboration">( such as amino acid intake )</segment>
<segment id="85" parent="1083" relname="same_unit">are effective</segment>
<segment id="86" parent="1086" relname="joint">in increasing muscle mass</segment>
<segment id="87" parent="1086" relname="joint">and improving muscle strength .</segment>
<segment id="88" parent="1087" relname="joint">Accordingly , not only exercise interventions</segment>
<segment id="89" parent="1088" relname="span">but also nutritional interventions</segment>
<segment id="90" parent="89" relname="elaboration">undertaken concurrently are expected to be effective against sarcopenia .</segment>
<group id="1000" type="span" />
<group id="1001" type="span" parent="1000" relname="span"/>
<group id="1002" type="span" parent="1" relname="elaboration"/>
<group id="1003" type="span" parent="2" relname="elaboration"/>
<group id="1004" type="multinuc" parent="3" relname="elaboration"/>
<group id="1005" type="multinuc" parent="1001" relname="elaboration"/>
<group id="1006" type="multinuc" parent="1005" relname="joint"/>
<group id="1007" type="multinuc" parent="1006" relname="joint"/>
<group id="1008" type="span" parent="1007" relname="joint"/>
<group id="1009" type="span" parent="6" relname="elaboration"/>
<group id="1010" type="span" parent="1007" relname="joint"/>
<group id="1011" type="span" parent="1010" relname="span"/>
<group id="1012" type="multinuc" parent="1006" relname="joint"/>
<group id="1013" type="span" parent="1012" relname="joint"/>
<group id="1014" type="multinuc" parent="1012" relname="joint"/>
<group id="1015" type="span" parent="1014" relname="same_unit"/>
<group id="1016" type="span" parent="14" relname="elaboration"/>
<group id="1017" type="multinuc" parent="1005" relname="joint"/>
<group id="1018" type="span" parent="1017" relname="joint"/>
<group id="1019" type="span" parent="1018" relname="span"/>
<group id="1020" type="multinuc" parent="1019" relname="elaboration"/>
<group id="1021" type="span" parent="1020" relname="same_unit"/>
<group id="1022" type="span" parent="20" relname="elaboration"/>
<group id="1023" type="multinuc" parent="1017" relname="joint"/>
<group id="1024" type="span" parent="1023" relname="joint"/>
<group id="1025" type="span" parent="24" relname="circumstance"/>
<group id="1026" type="span" parent="1025" relname="span"/>
<group id="1027" type="multinuc" parent="1023" relname="joint"/>
<group id="1028" type="span" parent="1027" relname="joint"/>
<group id="1029" type="multinuc" parent="1027" relname="joint"/>
<group id="1030" type="multinuc" parent="1029" relname="joint"/>
<group id="1031" type="multinuc" parent="1030" relname="joint"/>
<group id="1032" type="span" parent="1030" relname="joint"/>
<group id="1033" type="multinuc" parent="1029" relname="joint"/>
<group id="1034" type="span" parent="1033" relname="joint"/>
<group id="1035" type="span" parent="1034" relname="span"/>
<group id="1036" type="multinuc" parent="1035" relname="span"/>
<group id="1037" type="multinuc" parent="1036" relname="sequence"/>
<group id="1038" type="multinuc" parent="1035" relname="purpose"/>
<group id="1039" type="multinuc" parent="1038" relname="joint"/>
<group id="1040" type="multinuc" parent="1039" relname="joint"/>
<group id="1041" type="span" parent="1040" relname="same_unit"/>
<group id="1042" type="span" parent="40" relname="elaboration"/>
<group id="1043" type="multinuc" parent="1040" relname="same_unit"/>
<group id="1044" type="multinuc" parent="1043" relname="joint"/>
<group id="1045" type="span" parent="1039" relname="joint"/>
<group id="1046" type="span" parent="1047" relname="concession"/>
<group id="1047" type="multinuc" parent="1045" relname="span"/>
<group id="1048" type="multinuc" parent="1047" relname="joint"/>
<group id="1049" type="span" parent="1048" relname="same_unit"/>
<group id="1050" type="span" parent="48" relname="elaboration"/>
<group id="1051" type="span" parent="1048" relname="same_unit"/>
<group id="1052" type="multinuc" parent="1047" relname="joint"/>
<group id="1053" type="span" parent="1052" relname="joint"/>
<group id="1054" type="multinuc" parent="1052" relname="joint"/>
<group id="1055" type="multinuc" parent="1054" relname="joint"/>
<group id="1056" type="multinuc" parent="1054" relname="joint"/>
<group id="1057" type="span" parent="1056" relname="joint"/>
<group id="1058" type="span" parent="1060" relname="background"/>
<group id="1059" type="multinuc" parent="1058" relname="span"/>
<group id="1060" type="multinuc" parent="1057" relname="span"/>
<group id="1061" type="multinuc" parent="1060" relname="joint"/>
<group id="1062" type="span" parent="1061" relname="joint"/>
<group id="1063" type="span" parent="1061" relname="joint"/>
<group id="1064" type="multinuc" parent="1063" relname="span"/>
<group id="1065" type="multinuc" parent="1064" relname="joint"/>
<group id="1066" type="span" parent="1065" relname="same_unit"/>
<group id="1067" type="span" parent="1066" relname="span"/>
<group id="1068" type="span" parent="1064" relname="joint"/>
<group id="1069" type="multinuc" parent="68" relname="elaboration"/>
<group id="1070" type="multinuc" parent="1056" relname="joint"/>
<group id="1071" type="multinuc" parent="1070" relname="joint"/>
<group id="1072" type="span" parent="1071" relname="same_unit"/>
<group id="1073" type="multinuc" parent="1070" relname="joint"/>
<group id="1074" type="multinuc" parent="1073" relname="joint"/>
<group id="1075" type="span" parent="1074" relname="same_unit"/>
<group id="1076" type="multinuc" parent="1073" relname="joint"/>
<group id="1077" type="span" parent="1076" relname="joint"/>
<group id="1078" type="span" parent="1077" relname="span"/>
<group id="1079" type="multinuc" parent="1076" relname="joint"/>
<group id="1080" type="span" parent="1079" relname="joint"/>
<group id="1081" type="multinuc" parent="1079" relname="joint"/>
<group id="1082" type="span" parent="1081" relname="joint"/>
<group id="1083" type="multinuc" parent="1082" relname="span"/>
<group id="1084" type="span" parent="1083" relname="same_unit"/>
<group id="1085" type="span" parent="1084" relname="span"/>
<group id="1086" type="multinuc" parent="1083" relname="purpose"/>
<group id="1087" type="multinuc" parent="1081" relname="joint"/>
<group id="1088" type="span" parent="1087" relname="joint"/>
	</body>
</rst>
